Liver Failure
Hybrid artificial liver support systems can stem hepatic decline
Published in Hepatitis Weekly, September 1st, 2003
According to recent research from the Peoples Republic of China, "artificial liver support system (ALSS) has been used to treat hepatic failure and has significantly decreased mortality. TECA hybrid artificial liver support system (TECA-HALSS), which combines the hollow fiber bioreactor with a plasma exchange circuit, was used to assess the efficacy, safety and feasibility in treating severe hepatitis patients."
"The hybrid artificial liver support system (HALSS) consists of a bioreactor containing more than 5 x 109 porcine hepatocytes and plasma exchange device," explained...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-09-01)
More Articles from Hepatitis Weekly
- Immunology
Chromatin antibodies associate with autoimmune hepatitis pathology - Immunology
Inactivated parapoxvirus ovis protects against hepatitis and herpes viruses - Antimicrobial Resistance
Vancomycin-resistant infections are low among liver transplant candidates - HIV/AIDS Coinfection
SPECT imaging may replace liver biopsies in HIV/HCV coinfected patients - Viral Hepatitis
GBV-B infections in marmosets closely resemble human hepatitis C virology - Antiviral Therapy
Several factors contribute to treatment failure in chronic hepatitis C - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
